A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

NCT04089163 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision.

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: Toca 511
DRUG: Toca FC (extended-release formulation of flucytosine)

Sponsor

Tocagen Inc.